Yes and I think the last news release on 1/20/11 pretty much indicates what is going on within the company. They aren't messing around with their expansion goals.
They have all of the tools at their deposal now to shake up the pharma distribution world. They could be global by the end of the year or just remaining in China would give excellent profit margins.